The detector is a moderate flux device with a 4-channel readout and well capacity of 1 × 107 e− making it properly suited for the thermal background environment for a ground based imaging spectrometer.
Last year, the FDA also issued a proposed rule to reclassify tanning beds as "moderate risk" devices, a move that would mandate that the beds display warnings about the dangers of UV exposure.
But leaders of the Republican-controlled legislature who sponsored this year's legislation pointed to a call last year by the U.S. Acting Surgeon General to reduce sun-bed usage to help prevent skin cancer, and an announcement in May by the federal Food and Drug Administration that it was reclassifying tanning beds as moderate risk devices, from low risk.
Last year, the Food and Drug Administration proposed reclassifying tanning beds from "low-risk" to "moderate-risk" devices.
Last year the FDA allowed transcutaneous electrical nerve stimulator (TENS) machines for headache relief as it rated them as low-to moderate-risk devices.
"The committee concludes that the 510(k) process lacks the legal basis to be a reliable premarket screen of the safety and effectiveness" of moderate-risk devices, the report concluded, adding, "furthermore, that it cannot be transformed into one".
The panel urged the Food and Drug Administration to devise a new approval system for so-called moderate-risk devices — a category that now includes artificial hips, external heart defibrillators and hospital pumps — concluding that the current one was not fixable.
Bose went through the FDA's De Novo premarket review process, which is a regulatory pathway for low to moderate-risk devices that are especially novel, and not already available.
The results are clear: In a press release, IOM said the 501(k) process "lacks the legal basis to be a reliable premarket screen of the safety and effectiveness of moderate-risk" devices.
Still, the agency for the first time classified the fillings as a Class II, or "moderate risk," medical device.
